title: Amyotrophic lateral sclerosis developing during adalimumab therapy for psoriatic arthritis.
authors.affiliation: Department of Neurology, Athens National University, Aiginition Hospital, Vass. Sofias Ave. 72-74, 11528 Athens, Greece. Electronic address: annita139@yahoo.gr.
authors.forename: A
authors.initials: A
authors.lastname: Bougea
authors.affiliation: Department of Neurology, Athens National University, Aiginition Hospital, Vass. Sofias Ave. 72-74, 11528 Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Anagnostou
authors.affiliation: Department of Neurology, Athens National University, Aiginition Hospital, Vass. Sofias Ave. 72-74, 11528 Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Stamboulis
authors.affiliation: Department of Neurology, Athens National University, Aiginition Hospital, Vass. Sofias Ave. 72-74, 11528 Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Kararizou
mesh_terms: D000068879:Adalimumab; D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab